CompletedNCT02777931
NFC-1 for ADHD
This study is completed in the United States. It is testing NFC-1 for ADHD.
In BaltimoreADHDOtherFrom 12 Years to 17 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT04531982
Pimavanserin for schizophrenia
This study is completed in Argentina, in Bulgaria, in Croatia, .... It is testing pimavanserin for schizophrenia.
Multiple locations, including Buenos AiresSchizophreniaOtherFrom 18 Years to 55 Years
TerminatedNCT01467713
Ramelteon Sublingual for Bipolarity
This study has public registry information in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for Bipolarity.
Multiple locations, including BirminghamBipolarityOtherFrom 18 Years to 75 Years
TerminatedNCT01467700
Ramelteon Sublingual for depression
This study has public registry information in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for depression.
Multiple locations, including BirminghamDepression, BipolarityOtherFrom 18 Years to 75 Years
CompletedNCT03325881
SHP465 at 6.25 mg for ADHD
This study is completed in the United States. 25 mg for ADHD.
Multiple locations, including DothanADHDOtherFrom 6 Years to 12 Years
CompletedNCT00150579
SPD465 for ADHD
This study is completed in Global. It is testing SPD465 for ADHD.
In GlobalADHDOtherFrom 18 Years to 55 Years
CompletedNCT00152022
SPD465 for ADHD
This study is completed in Global. It is testing SPD465 for ADHD.
In GlobalADHDOtherFrom 18 Years to 55 Years
CompletedNCT00734578
SPD503 for ADHD
This study is completed in the United States. It is testing SPD503 for ADHD.
Multiple locations, including DothanADHDOtherFrom 6 Years to 17 Years
CompletedNCT02633527
SPN-812 (Viloxazine Extended-release Capsule) for ADHD
This study is completed in the United States. It is testing SPN-812 (Viloxazine Extended-release Capsule) for ADHD.
In MaitlandADHDOtherFrom 6 Years to 12 Years
CompletedNCT00782080
St. John´s Wort/Valerian Extract for ADHD
This study is completed in Germany. It is testing st.
Multiple locations, including AlzeyADHDOtherFrom 6 Years to 17 Years
Active Not RecruitingNCT07184697
Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD.
This study is active but not recruiting in China. It focuses on Depression.
In ShanghaiDepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
UnknownNCT06270433
Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia for depression
This study has public registry information in China. It is testing Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia for depression.
In NanjingDepressionDrugA study involving a medication or substance.From 18 Years to 65 Years